New pill targets hormone imbalance from adrenal tumors
NCT ID NCT05436639
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a daily pill called SPI-62 in 30 adults with high cortisol levels caused by a non-cancerous adrenal tumor. The goal was to see if the drug could safely lower blood sugar and improve other health measures. Participants took 2 mg of SPI-62 each day for up to 12 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTH-INDEPENDENT ADRENAL CUSHING SYNDROME, SOMATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
C.M.D.T.A. Neomed
Brasov, 500283, Romania
-
Institutul National de Endocrinologie
Bucharest, 11863, Romania
-
King's College Hospital
London, SW9 8RR, United Kingdom
-
Mayo Clinic Cancer Center (MCCC) - Rochester
Rochester, Minnesota, 55905, United States
-
Ohio State McCampbell Outpatient Care
Columbus, Ohio, 43210, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.